Edesa Biotech to Present at Upcoming H.C. Wainwright Investor Conference
Edesa Biotech (NASDAQ:EDSA) announced that CEO Par Nijhawan will present at the H.C. Wainwright Global Investment Conference in New York from September 12-14, 2022. The presentation is scheduled for September 12 at 10:00 am Eastern Time, and slides will be available on the Edesa website. Edesa is focused on developing treatments for inflammatory diseases, with key products, EB05 for ARDS and EB01 for chronic allergic contact dermatitis, in late-stage studies.
- None.
- None.
TORONTO, ON / ACCESSWIRE / September 8, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that Par Nijhawan, MD, Chief Executive Officer, will present at the H.C. Wainwright Global Investment Conference being held in New York, NY on September 12-14, 2022.
Edesa Presentation Details
Date: September 12, 2022
Time: 10:00 am Eastern Time
Presentation Slides: Available in the events section of the Edesa website.
Attendees who are interested in meeting with the company should contact their H.C. Wainwright representative or Edesa directly via email at investors@edesabiotech.com.
About Edesa Biotech, Inc.
Edesa Biotech, Inc. (NASDAQ:EDSA) is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases with clear unmet medical needs. The company's two lead product candidates, EB05 and EB01, are in later stage clinical studies. EB05 is a monoclonal antibody therapy that Edesa is developing as a treatment for Acute Respiratory Distress Syndrome (ARDS). Edesa is also developing an sPLA2 inhibitor, designated as EB01, as a topical treatment for chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness. Sign up for news alerts. Connect with Edesa Biotech on Twitter and LinkedIn.
Contact
Gary Koppenjan
Edesa Biotech, Inc.
(805) 488-2800 ext. 150
investors@edesabiotech.com
SOURCE: Edesa Biotech
View source version on accesswire.com:
https://www.accesswire.com/715058/Edesa-Biotech-to-Present-at-Upcoming-HC-Wainwright-Investor-Conference
FAQ
When is Edesa Biotech presenting at the H.C. Wainwright Global Investment Conference?
What is the focus of Edesa Biotech's research?
What are Edesa Biotech's lead product candidates?
How can I access the presentation slides from Edesa Biotech's conference?
How can I contact Edesa Biotech for a meeting at the conference?
